Welcome to our dedicated page for Marimed news (Ticker: MRMD), a resource for investors and traders seeking the latest updates and insights on Marimed stock.
Marimed Inc. (MRMD) operates as a vertically integrated cannabis company with a regulated seed-to-sale approach across multiple states. This page aggregates official press releases and verified news about the company’s cultivation practices, product innovations, and market expansions.
Investors and industry professionals will find timely updates on MRMD’s operational milestones, including regulatory compliance developments, retail dispensary openings, and wholesale distribution partnerships. The curated collection includes earnings reports, leadership announcements, and strategic initiatives shaping the company’s position in the cannabis sector.
Key content categories cover facility certifications, new market entries, product line expansions, and compliance achievements. All materials reflect MRMD’s commitment to operating within strict regulatory frameworks while maintaining product consistency through GMP-certified production processes.
Bookmark this page for direct access to primary-source information about Marimed’s operational and financial developments. Check regularly for updates impacting the company’s performance in evolving cannabis markets.
MariMed Inc. (OTCQX: MRMD) has entered into a definitive agreement to acquire Kind Therapeutics U.S.A., LLC for $20 million, marking a strategic expansion into Maryland’s cannabis market. The acquisition is subject to regulatory approvals and aims to consolidate MariMed's operations, enhancing its growth trajectory following two years of over 100% revenue growth. Kind holds essential cannabis licenses and operates from a 180,000 sq. ft. facility developed by MariMed, contributing to Maryland’s thriving cannabis industry, which serves over 139,000 registered patients.
MariMed, Inc. (MRMD) reported impressive financial results for Q3 2021, with revenue of $33.2 million, a 147% increase year-over-year. The adjusted EBITDA reached $12.9 million, marking a 213% increase compared to the same quarter last year. Net income rose to $2.1 million, up 25% year-over-year. The company also maintained working capital of $27.3 million. MariMed’s retail operations in Illinois and Massachusetts saw revenue growth of 207% year-over-year, demonstrating strong performance despite an industry-wide slowdown. Full-year guidance remains at $118 million in revenue and $42 million in adjusted EBITDA.
MariMed, Inc. (OTCQX: MRMD), a multi-state cannabis operator, announced it will release its third quarter 2021 financial results on November 15, 2021, after market close. Management will hold a conference call on November 16, 2021, at 8:00 a.m. EDT to discuss these results. The call will be accessible via the company's Investor Relations website, with a playback available for 30 days. MariMed is focused on providing high-quality cannabis products and has developed a robust portfolio, including brands like Betty's Eddies® and Nature’s Heritage™.
MariMed, Inc. (OTCQX: MRMD) announced the appointment of Steve West as Vice President of Investor Relations. With nearly 20 years of experience, West has held significant roles at renowned companies like Neptune Wellness Solutions and Acreage Holdings. He is recognized for his expertise in investor relations, previously serving as a successful sell-side analyst. His military background includes over 14 years in the U.S. Navy. This strategic appointment aims to enhance MariMed's communication with capital markets and strengthen investor relations.
MariMed, Inc. (OTCQX: MRMD) announced health and safety protocols for its annual meeting on September 23, 2021, at Hilton Boston/Dedham. Only stockholders will be admitted, with record stockholders confirmed from company records. Attendees must present proof of vaccination or a negative COVID-19 test within 72 hours. Masks are mandatory, and no food or beverages are allowed. The company focuses on health and wellness in the cannabis sector, managing state-licensed facilities and producing award-winning products such as Betty's Eddies® and Nature’s Heritage™.
MariMed, Inc. (OTCQX: MRMD) has launched new SKUs of its popular Betty’s Eddies cannabis-infused fruit chews, introducing single-serving options and multi-packs after customer requests. The single-serving packs aim to enhance trial among new consumers and facilitate impulse purchases. Multi-packs will feature an assortment of classic flavors, allowing users to explore different options. Betty’s Eddies chews are made with full-spectrum cannabis oil and organic ingredients, and are already the leading cannabis edible in Maryland and Massachusetts.
MariMed, Inc. (OTCQX: MRMD), a multi-state cannabis operator, announced its participation in several upcoming conferences. CEO Bob Fireman will present at the Cannabis Virtual Investor Conference on September 8th and the Echelon Capital Markets U.S. MSO Cannabis Conference on September 22nd. Additionally, management will hold one-on-one meetings at the Beacon Securities Virtual Cannabis Conference on September 9th. Fireman will also participate in a panel discussion at the Burns Levinson Conference on September 28th. MariMed is dedicated to high-quality cannabis products and has shown consistent growth.
FAQ
What is the current stock price of Marimed (MRMD)?
What is the market cap of Marimed (MRMD)?
